NAVLE Endocrine

Canine Hypoparathyroidism Study Guide

📅 March 28, 2026 ⏱ 25 min read 👁 1 views

Hypoparathyroidism is an uncommon but clinically significant endocrine disorder in dogs characterized by deficient or absent secretion of parathyroid hormone (PTH) from the parathyroid glands.

Overview and Clinical Importance

Hypoparathyroidism is an uncommon but clinically significant endocrine disorder in dogs characterized by deficient or absent secretion of parathyroid hormone (PTH) from the parathyroid glands. This deficiency results in hypocalcemia (low blood calcium) and hyperphosphatemia (elevated blood phosphorus), leading to potentially life-threatening neuromuscular and cardiovascular complications.

While hypoparathyroidism is relatively rare, it represents an important differential diagnosis for any dog presenting with neuromuscular signs such as tremors, tetany, or seizures. Early recognition and appropriate treatment are essential, as untreated hypocalcemia can be fatal. The condition is highly manageable with lifelong therapy, and affected dogs can achieve a normal quality of life with proper monitoring.

Target Organ	PTH Actions
Bone	Stimulates osteoclast activity, promoting calcium and phosphorus release from bone into blood
Kidney	Increases calcium reabsorption in distal tubules; Increases phosphorus excretion (phosphaturia); Stimulates 1-alpha-hydroxylase to convert 25-hydroxyvitamin D to active calcitriol
Intestine (Indirect)	Via calcitriol production, increases intestinal calcium and phosphorus absorption

Pathophysiology

Calcium Homeostasis

Calcium plays an essential role in numerous physiological processes including neuromuscular transmission, muscle contraction, blood coagulation, enzyme activation, and bone formation. Approximately 99% of body calcium is stored in bone, with only 1% in soft tissue and blood. Of circulating calcium, about 50% is ionized (free) and biologically active, 40% is bound to proteins (primarily albumin), and 10% is complexed with anions.

Three primary hormones regulate calcium homeostasis: parathyroid hormone (PTH), calcitriol (active vitamin D), and calcitonin. PTH is the most critical for maintaining ionized calcium within the narrow physiological range of 1.25-1.45 mmol/L.

Actions of Parathyroid Hormone

PTH is secreted by chief cells of the parathyroid glands in response to decreased ionized calcium. PTH has a short half-life of only 3-5 minutes, allowing rapid physiological responses. The calcium-sensing receptors (CaSR) on parathyroid chief cells detect even small changes in calcium concentration, triggering appropriate PTH release.

PTH Target Organ Actions

Consequences of PTH Deficiency

In hypoparathyroidism, the absence or deficiency of PTH leads to: decreased bone resorption and calcium release, decreased renal calcium reabsorption, increased renal phosphorus reabsorption (hyperphosphatemia), decreased calcitriol synthesis, and decreased intestinal calcium absorption. The resulting hypocalcemia causes increased neuromuscular excitability.

High-YieldThe hallmark laboratory findings in primary hypoparathyroidism are hypocalcemia WITH hyperphosphatemia AND low or inappropriately normal PTH. This triad distinguishes it from other causes of hypocalcemia where PTH is typically elevated as a compensatory response.

Type	Description and Mechanism
Primary (Idiopathic) - Most Common	Immune-mediated lymphocytic parathyroiditis causing destruction of parathyroid chief cells. Histopathology shows lymphocytic infiltration, fibrosis, and loss of secretory parenchyma.
Iatrogenic (Post-surgical)	Inadvertent removal or damage during thyroidectomy or parathyroidectomy. May be temporary (weeks to months) if functional tissue regenerates.
Neoplastic Destruction	Destruction by primary or metastatic neoplasms in the cervical region (rare)
Congenital Agenesis	Rare failure of parathyroid gland development (presents in young puppies)

Etiology and Classification

Parameter	Description
Age	Mean age 4.8-7 years (range: 6 weeks to 13 years); typically young to middle-aged
Sex	Female predisposition (60-65% of cases are female dogs)
Breed Predisposition	High risk: Miniature Schnauzer, Toy Poodle, Standard Schnauzer, Scottish Terrier, West Highland White Terrier, Labrador Retriever, German Shepherd, Dachshund. Also reported: St. Bernard, Chihuahua, Jack Russell Terrier

Signalment and Breed Predisposition

NAVLE TipThink of hypoparathyroidism when you see a middle-aged, female, small-breed dog (especially Miniature Schnauzer or Toy Poodle) presenting with episodic muscle tremors, tetany, or seizures. The classic board stem often describes signs that worsen with excitement or exercise.

Category	Clinical Manifestations
Early/Mild Signs	Restlessness, nervousness, panting, facial rubbing, paw licking/chewing, muscle tremors, stiff gait, ataxia
Severe Signs	Generalized tetany, tonic-clonic seizures, hyperthermia (secondary to muscle activity)
Cardiovascular	Bradycardia, weak pulses, hypotension, prolonged QT interval on ECG
Ophthalmic (Chronic)	Bilateral punctate-to-linear cataracts in anterior and posterior cortical subcapsular region

Clinical Signs

Clinical signs result from increased neuromuscular excitability due to hypocalcemia. The severity correlates with the rate of decline and magnitude of ionized calcium decrease. Signs may be episodic and exacerbated by stress, exercise, or excitement.

High-YieldFacial rubbing is a characteristic and common sign in dogs with hypoparathyroidism (seen in approximately 60% of cases). This is thought to result from paresthesia (tingling sensation) or cramping of the masseter and temporal muscles.

Parameter	Finding	Clinical Significance
Total Calcium	Less than 6.5 mg/dL	Normal: 9.5-11.5 mg/dL
Ionized Calcium	Less than 0.8 mmol/L	Most reliable; normal: 1.25-1.45 mmol/L
Phosphorus	Elevated	Often greater than calcium value
PTH	Low or inappropriately normal	KEY diagnostic finding
BUN/Creatinine	Normal	Excludes renal failure

Diagnosis

Diagnostic Criteria

Diagnosis is based on: clinical signs of neuromuscular excitability, severe hypocalcemia (total calcium less than 6.5 mg/dL; ionized calcium less than 0.8 mmol/L), hyperphosphatemia, low or inappropriately normal PTH, normal renal function, and exclusion of other causes of hypocalcemia.

Laboratory Findings

Electrocardiographic Findings

The hallmark finding is QT interval prolongation due to ST segment prolongation. This occurs because hypocalcemia prolongs phase 2 (plateau phase) of the cardiac action potential.

Condition	Key Features	PTH Level
Eclampsia	Nursing female within 21 days of whelping; hypophosphatemia	Elevated
Chronic Renal Failure	Azotemia, PU/PD	Elevated
Acute Pancreatitis	Vomiting, abdominal pain	Elevated
Ethylene Glycol Toxicity	Acute renal failure, calcium oxalate crystals	Elevated
Hypoalbuminemia	Low total Ca but NORMAL ionized Ca	Normal

Differential Diagnosis for Hypocalcemia

Treatment	Protocol
IV Bolus	0.5-1.5 mL/kg of 10% calcium gluconate IV SLOWLY over 10-30 minutes with ECG monitoring. Stop if bradycardia or arrhythmias develop.
CRI	10 mL of 10% calcium gluconate in 250 mL 0.9% saline at 2.5 mL/kg/hour for 8-12 hours. Goal: maintain serum calcium 8-9 mg/dL.

Treatment

Emergency Treatment

Dogs with tetany, seizures, or severe signs require immediate IV calcium. 10% Calcium gluconate is preferred because it is less irritating than calcium chloride if extravasation occurs.

High-YieldNEVER administer calcium rapidly IV - it is cardiotoxic and can cause fatal arrhythmias. Always administer slowly over 10-30 minutes with ECG monitoring. Avoid alkalinizing fluids as alkalosis decreases ionized calcium.

Long-Term Maintenance Therapy

Lifelong vitamin D analogue therapy is the mainstay of treatment. Calcitriol (active vitamin D) is preferred due to its rapid onset and short half-life.

NAVLE TipFor NAVLE questions: (1) Emergency = IV calcium gluconate slowly with ECG monitoring; (2) Long-term = Calcitriol (active vitamin D) is preferred; (3) Goal calcium = 8-9.5 mg/dL (slightly below normal to minimize hypercalcemia risk); (4) Oral calcium is temporary until vitamin D takes effect.

Drug	Dosage	Onset	Notes
Calcitriol (Rocaltrol)	Loading: 20-40 ng/kg/day divided BID for 2-4 days; Maintenance: 5-20 ng/kg/day divided BID	1-4 days	PREFERRED
Dihydrotachysterol	0.02-0.03 mg/kg/day divided BID	1-7 days	Alternative

Monitoring and Prognosis

Monitoring: Serum calcium daily during acute stabilization, weekly during initial oral therapy, then monthly to every 3-6 months once stable. Iatrogenic hypercalcemia is the most common complication and can cause renal failure.

Prognosis: With appropriate treatment and monitoring, prognosis is excellent. Dogs can live a normal lifespan with good quality of life. For iatrogenic hypoparathyroidism, function often returns within weeks to months.

HypoPara = Low PTH = Low Ca, High Phos

Remember the lab pattern: PTH is low or inappropriately normal, calcium is low, phosphorus is high.

"TWITCHY" Mnemonic for Clinical Signs:

T - Tetany and Tremors

W - Weakness

I - Irritability and facial rubbing

T - Twitching (especially face)

C - Convulsions/seizures

H - Heart changes (prolonged QT)

Y - Young to middle-aged female dogs

"SCHNAUZERS and POODLES" = Think HypoPara

Miniature Schnauzers and Toy Poodles are the classic predisposed breeds.

"SLOW CALCIUM, LIFELONG D"

SLOW CALCIUM - Emergency IV calcium gluconate SLOWLY with ECG monitoring

LIFELONG D - Vitamin D (calcitriol preferred) is required LIFELONG

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →